Diabetes drug turned weight loss med spurs cost-benefit concerns for docs
By
Alicia Lasek
Aug 13, 2021
The high price tag and lack of coverage for high-performing anti-obesity drug Wegovy begs the question of what the benefits of weight loss are worth to insurers and patients.
ADA: Diabetes may quadruple risk for long COVID
Jun 08, 2022
Diabetes may increase the risk for long COVID symptoms fourfold, according to research presented at the annual meeting of the American Diabetes Association.
Universal screening to age 70 identifies diabetes in most cases
Apr 07, 2023
An age-based screening method (35 to 70) identifies the greatest proportion of adults with prediabetes and diabetes compared with USPSTF recommendations and BMI-based screening, investigators say.
ADA: Screen adults with type 2 diabetes for nonalcoholic fatty liver disease
By
Alicia Lasek
Jun 27, 2023
A new guideline update reflects the increased recognition that liver disease is a major complication of diabetes, the American Diabetes Association reports.
Common diabetes drug may serve as novel Afib treatment
By
Alicia Lasek
Oct 13, 2022
If approved, it would be the first new drug identified to treat this disease of the heart in a decade, according to Cleveland Clinic researchers.
Most US adults with type 2 diabetes meet criteria for GLP-RAs, SGLT2is
Feb 28, 2023
More than 82% US adults with type 2 diabetes meet the criteria to be prescribed the drugs, yet only 9% use either of them.
Diabetes indicators improve with use of health incentives, CDC study finds
By
Alicia Lasek
Nov 10, 2022
Incentivizing patients to follow a lifestyle modification program helps them to improve a full range of diabetes-related health measures, according to a new meta-analysis.
Analysis: Medication adherence spotty among U.S. diabetes patients
By
Alicia Lasek
Feb 01, 2023
A sizable percentage of patients with diabetes do not consistently take prescribed medications to lower cholesterol, glucose or blood pressure, investigators say.